The Task Force:
|Apostolou, Effie||WCM Molecular Biology in Medicine|
|Baird, Barbara||Chemistry and Chemical Biology|
|Bogdanove, Adam||Plant Pathology and Plant-Microbe Biology Section|
|Cantley, Lew||Weill Department of Medicine|
|Cerione, Rick||Chemistry and Chemical Biology|
|Clark, Andy||Molecular Biology and Genetics|
|Cohen, Paula||Biomedical Sciences|
|Feschotte, Cedric||Molecular Biology and Genetics|
|Fischbach-Teschl, Claudia||Biomedical Engineering|
|Lipkin, Steve||Weill Department of Medicine|
|Lis, John||Molecular Biology and Genetics|
|Shu-Bing Qian||Nutritional Sciences|
|Sethupathy, Praveen||Biomedical Sciences|
|Soloway, Paul||Nutritional Sciences|
|Yu, Haiyuan||Biological Statistics and Computational Biology|
- November 2017 Task Force Report (pdf)
The Genome Biology Task Force will develop a strategic plan that includes recommendations to shape future recruitment, graduate training, and infrastructure investments for the coming years. While the plan will shape investments on the Ithaca campus, the task force includes key participants from Weill Cornell Medicine in order to further unify our campuses academically and take advantage of aggregate strengths in genomics and genomic medicine in developing multi-investigator proposals.
The task force will shape and strengthen programs in gene regulation, genomics, gene repair, and genetic medicine, as well as other areas of basic and applied biology. The planning exercise should be completed within the 2016-17 academic year, and it is anticipated that the task force will play a critical, ongoing role in coordinating and facilitating recruitments, fostering collaborations, and implementing other aspects of the recommendations.
Contact Genome Biology Task Force lead.